Stanley Laman Group, Ltd. Albemarle Corp Transaction History

Stanley Laman Group, Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$50.9 - $94.31 $220,040 - $407,702	-4,323 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$60.74 - $73.04 $27,515 - $33,087	-453 Reduced 9.48%	4,323 $316,000
Q3 2019 Nov 08, 2019	SELL	$59.3 - $75.53 $51,531 - $65,635	-869 Reduced 15.39%	4,776 $332,000
Q2 2019 Aug 01, 2019	SELL	$63.3 - $86.94 $13,229 - $18,170	-209 Reduced 3.57%	5,645 $397,000
Q1 2019 May 10, 2019	BUY	$72.69 - $92.28 $25,296 - $32,113	348 Added 6.32%	5,854 $480,000
Q4 2018 Feb 07, 2019	SELL	$73.13 - $107.99 $12,505 - $18,466	-171 Reduced 3.01%	5,506 $424,000
Q3 2018 Oct 30, 2018	SELL	$90.9 - $106.6 $46,540 - $54,579	-512 Reduced 8.27%	5,677 $566,000
Q2 2018 Aug 09, 2018	BUY	$88.96 - $104.92 $58,446 - $68,932	657 Added 11.88%	6,189 $584,000
Q1 2018 May 01, 2018	SELL	$89.56 - $137.45 $14,956 - $22,954	-167 Reduced 2.93%	5,532 $513,000
Q4 2017 Feb 09, 2018	BUY	$127.48 - $144.58 $726,508 - $823,961	5,699	5,699 $729,000

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.